Vol 57, No 4 (2019)
Commentary
Published online: 2019-11-19
Transforming growth factor-β activation in cell-free extracellular matrix preparations. Commentary
1
Abstract
Transforming growth factor-β (TGF-β) is an important regulator of many cellular and immunological functions. It is often deposited in extracellular matrices in a latent form. This commentary is to draw attention to the likelihood that preparing cell-free matrices from tissue cultures by high pH buffers, such as ammonium hydroxide, can activate the TGF-β. Therefore, cells subsequently seeded onto such matrices may respond to the presence of active TGF-β in addition to interactions with macromolecular extracellular matrix components.
Keywords: TGF-βlatent TGF-binding proteincell free ECMhigh pH buffers
References
- Gospodarowicz D, Ill C. The extracellular matrix and the control of proliferation of corneal endothelial and lens epithelial cells. Exp Eye Res. 1980; 31(2): 181–199.
- Gospodarowicz D, Hirabayashi K, Giguère L, et al. Factors controlling the proliferative rate, final cell density, and life span of bovine vascular smooth muscle cells in culture. J Cell Biol. 1981; 89(3): 568–578.
- Gospodarowicz D, Gonzalez R, Fujii DK. Are factors originating from serum, plasma, or cultured cells involved in the growth-promoting effect of the extracellular matrix produced by cultured bovine corneal endothelial cells? J Cell Physiol. 1983; 114(2): 191–202.
- Lawrence DA, Pircher R, Jullien P. Conversion of a high molecular weight latent beta-TGF from chicken embryo fibroblasts into a low molecular weight active beta-TGF under acidic conditions. Biochem Biophys Res Commun. 1985; 133(3): 1026–1034.
- Lyons RM, Keski-Oja J, Moses HL. Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol. 1988; 106(5): 1659–1665.
- Munger JS, Harpel JG, Gleizes PE, et al. Latent transforming growth factor-beta: structural features and mechanisms of activation. Kidney Int. 1997; 51(5): 1376–1382.
- Schultz-Cherry S, Murphy-Ullrich JE. Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. J Cell Biol. 1993; 122(4): 923–932.
- Barcellos-Hoff MH, Dix TA. Redox-mediated activation of latent transforming growth factor-beta 1. Mol Endocrinol. 1996; 10(9): 1077–1083.
- Wipff PJ, Hinz B. Integrins and the activation of latent transforming growth factor beta1 - an intimate relationship. Eur J Cell Biol. 2008; 87(8-9): 601–615.
- Hinz B. It has to be the αv: myofibroblast integrins activate latent TGF-β1. Nat Med. 2013; 19(12): 1567–1568.
- Rifkin DB, Rifkin WJ, Zilberberg L. LTBPs in biology and medicine: LTBP diseases. Matrix Biol. 2018; 71-72: 90–99.
- Taipale J, Miyazono K, Heldin CH, et al. Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein. J Cell Biol. 1994; 124(1-2): 171–181.
- Dallas SL, Miyazono K, Skerry TM, et al. Dual role for the latent transforming growth factor-beta binding protein in storage of latent TGF-beta in the extracellular matrix and as a structural matrix protein. J Cell Biol. 1995; 131(2): 539–549.
- Cheifetz S, Weatherbee JA, Tsang ML, et al. The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors. Cell. 1987; 48(3): 409–415.
- Vlodavsky I. Preparation of extracellular matrices produced by cultured corneal endothelial and PF-HR9 endodermal cells. Curr Protoc Cell Biol. 2001; Chapter 10: Unit 10.4.
- Franco-Barraza J, Beacham DA, Amatangelo MD, et al. Preparation of Extracellular Matrices Produced by Cultured and Primary Fibroblasts. Curr Protoc Cell Biol. 2016; 71: 10.9.1–10.9.34.
- Hellewell AL, Rosini S, Adams JC. A Rapid, Scalable Method for the Isolation, Functional Study, and Analysis of Cell-derived Extracellular Matrix. J Vis Exp. 2017(119).
